The Official Comment of AHRMM to the United States Department of Health and Human Services Food and Drug Administration (FDA) regarding Unique Device Identification for Medical Devices Docket No. FDA-2011-N-0090
AHRMM comments to the FDA regarding an amendment to the UDI proposed rule to address the UDI implementation time frame required by the 2012 Food and Drug Administration Safety and Innovation Act (FDASIA).
Related Resources
Podcasts
In this session, Dennis Black and Dennis Orthman share their experiences and best practices to improve and expand the provider-supplier relationship.
e-Learning
Become an expert in health care inventory management with AHRMM's certification program. Gain the skills to optimize your supply chain. Enroll now!
Webcast
In part 2 of the GPO or Local/Self Contracting webcast series, the panel considers the multiple product categories and the process of choosing the
On-Demand Educational Webinars
Hospitals need a tool to leverage the use of UDI within their health care organizations to empower the Cost, Quality, Outcomes Movement. This webinar…
Webcast
The intersection of CQO is patient care, Deborah Rey presents ten commandments you should adopt if they're not already part of your values both…